We investigated the potential of plasma for brain cancer cells to alter the oxidative stress pathway and identified PI3K/Akt, P53 and total MAPK signaling pathways as part of the anti-cancer effects of NBP-J. The gene discussed is TP53; the disease is brain cancer.